VolitionRx Limited Gain (Loss) on Disposition of Intangible Assets
VolitionRx Limited (VNRX) reported Gain (Loss) on Disposition of Intangible Assets of -$26.17 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfIntangibleAssets · last filed 2022-03-30
- VolitionRx Limited gain (loss) on disposition of intangible assets for the quarter ending 2021-12-31 was -$52.33K, a 108.92% decline year-over-year.
- VolitionRx Limited gain (loss) on disposition of intangible assets for the quarter ending 2021-09-30 was $1.00.
- VolitionRx Limited gain (loss) on disposition of intangible assets for the quarter ending 2020-12-31 was $586.91K.
- VolitionRx Limited gain (loss) on disposition of intangible assets for the quarter ending 2020-09-30 was -$200.39K.
- VolitionRx Limited gain (loss) on disposition of intangible assets for fiscal 2021 was -$26.17K, a 108.92% decline from fiscal 2020.
- VolitionRx Limited gain (loss) on disposition of intangible assets for fiscal 2020 was $293.31K.
| Period end | Gain (Loss) on Disposition of Intangible Assets 3 month | Gain (Loss) on Disposition of Intangible Assets 6 month | Gain (Loss) on Disposition of Intangible Assets 9 month | Gain (Loss) on Disposition of Intangible Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$52.33K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$52.33K derived: sum of 2 quarters · filed 2022-03-30 | -$26.17K 10-K · filed 2022-03-30 | |
| 2021-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $26.17K 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $26.17K 10-Q · filed 2021-08-11 | |||
| 2020-12-31 | $586.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $386.51K derived: sum of 2 quarters · filed 2022-03-30 | $293.31K 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$200.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$293.60K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$93.20K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |